Curaleaf Holdings Company Description

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally.

The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of hemp-derived THC products through wholesale channels.

The company is headquartered in Stamford, Connecticut.

Curaleaf Holdings, Inc.

Country	Canada
Founded	2010
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	5,519
CEO	Boris Jordan

Contact Details

Address: 290 Harbor Drive Stamford, British Columbia 06902 United States
Website	curaleaf.com

Stock Details

Ticker Symbol	CURA
Exchange	Toronto Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CA23126M1023
SIC Code	2834

Key Executives

Name	Position
Boris Alexis Jordan	Chief Executive Officer and Chairman
Joseph F. Lusardi	Executive Vice-Chairman
Edward Kremer	Chief Financial Officer
Peter Laurence Clateman J.D.	Chief Legal Officer
Matthew S. Darin	Special Advisor
Camilo Russi Lyon	Chief Investment Officer
Christine Taylor	Chief Accounting Officer
Scott Baughman	Chief Technology Officer
James S. Shorris	Chief Compliance Officer
Kate Lynch	Executive Vice President of Marketing